Skip to main content
SpringerLink
Log in
Book cover

Ergot Alkaloids and Related Compounds pp 567–614Cite as

Some Compounds With Hallucinogenic Activity

  • Chapter

Abstract

Although “delusional insanity” has been reported among the manifestations of convulsive ergotism (Barger, 1931), none of the naturally occurring ergot alkaloids have typical hallucinogenic properties; such properties are confined to a number of semisynthetic derivatives of lysergic acid, the prototype of which is LSD. This substance is the most potent and, by far, the most extensively tested hallucinogen derived from ergot.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abramson, H.A.: Lysergic acid diethylamide (LSD-25): III. As an adjunct to psychotherapy with elimination of fear of homosexuality. J. Psychol. 39, 127–155 (1955)

    Google Scholar 

  • Abramson, H.A.: Lysergic acid diethylamide (LSD-25): XIX. As an adjunct to brief psychotherapy, with special reference to ego enhancement. J. Psychol. 41, 199–229 (1956a)

    Google Scholar 

  • Abramson, H.A.: Lysergic acid diethylamide (LSD-25): XXII. Effect on transference. J. Psychol. 42, 51–98 (1956b)

    Google Scholar 

  • Abramson, H.A.: Verbatim recording and transference studies with lysergic acid diethylamide (LSD-25). J. nerv. ment. Dis. 125, 444–450 (1957)

    PubMed  CAS  Google Scholar 

  • Abramson, H.A.: Lysergic acid diethylamide (LSD-25): XXIX. The response index as a measure of threshold activity of psychotropic drugs in man. J. Psychol. 48, 65–78 (1959)

    CAS  Google Scholar 

  • Abramson, H.A.: Lysergic acid diethylamide (LSD-25): XXX. The questionnaire technique with notes on its use. J. Psychol. 49, 57–65 (1960a)

    Google Scholar 

  • Abramson, H.A.: Psychoanalytic psychotherapy with LSD. In: The Use of LSD in Psychotherapy. Transactions of a Conference on d-Lysergic Acid Diethylamide (LSD-25). April 22–24, 1959. Abramson, H.A. (ed.), pp. 25–80. New York: Josiah Macy, Jr., Foundation 1960b

    Google Scholar 

  • Abramson, H.A., Sklarofsky, B.: Lysergic acid diethylamide (LSD-25) antagonists. III. Modifications of syndrome by prior administration of prednisone. Arch. gen. Psychiat. 2, 89–93 (1960)

    CAS  Google Scholar 

  • Abramson, H.A., Jarvik, M.E., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): VII. Effect upon two measures of motor performance. J. Psychol. 39, 455–464 (1955a)

    Google Scholar 

  • Abramson, H.A., Jarvik, M.E., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): X. Effect on reaction time to auditory and visual stimuli. J. Psychol. 40, 39–52 (1955b)

    Google Scholar 

  • Abramson, H.A., Jarvik, M.E., Hirsch, M.W., Ewald, A.T.: Lysergic acid diethylamide (LSD-25): V. Effect on spatial relations abilities. J. Psychol. 39, 435–442 (1955c)

    Google Scholar 

  • Abramson, H.A., Jarvik, M.E., Kaufman, M.R., Kornetsky, C., Levine, A., Wagner, M.: Lysergic acid diethylamide (LSD-25): I. Physiological and preceptual responses. J. Psychol. 39, 3–60 (1955d)

    CAS  Google Scholar 

  • Abramson, H.A., Jarvik, M.E., Levine, A., Kaufman, M.R., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): XV. The effects produced by substitution of a tap water placebo. J. Psychol. 40, 367–383 (1955e)

    Google Scholar 

  • Abramson, H.A., Waxenberg, S.E., Levine, A., Kaufman, M.R., Kornetsky, C.: Lysergic acid diethylamide (LSD-25): XIII. Effect on Bender-Gestalt test performance. J. Psychol. 40, 341–349 (1955)

    Google Scholar 

  • Abramson, H.A., Jarvik, M.E., Gorin, M.H., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): XVII. Tolerance development and its relationship to a theory of psychosis. J. Psychol. 41, 81–105 (1956)

    CAS  Google Scholar 

  • Abramson, H.A., Hewitt, M.P., Lennard, H., Turner, W.J., O’Neill, F.J., Merlis, S.: The stablemate concept of therapy as affected by LSD in schizophrenia. J. Psychol. 45, 75–84 (1958a)

    Google Scholar 

  • Abramson, H.A., Sklarosfky, B., Baron, M.O., Fremont-Smith, N.: Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide). Arch. Neurol. Psychiat. (Chic.) 79, 201–207 (1958b)

    CAS  Google Scholar 

  • Abramson, H.A., Rolo, A., Sklarofsky, B., Stache, J.: Production of cross-tolerance to psychosis-producing doses of lysergic acid diethylamide and psilocybin. J. Psychol. 49, 151–154 (1960a)

    Google Scholar 

  • Abramson, H.A., Rolo, A., Stache, J.: Lysergic acid diethylamide (LSD-25) antagonists: chlorpromazine. J. Neuropsychiat. 1, 307–310 (1960b)

    PubMed  CAS  Google Scholar 

  • Abuzzahab, F.S., Anderson, B.J.: A review of LSD treatment in alcoholism. Int. Pharmacopsychiat. 6, 223–235 (1971)

    Google Scholar 

  • Agnew, N., Hoffer, A.: Nicotinic acid modified lysergic acid diethylamide psychosis. J. ment. Sci. 101, 12–27 (1955)

    PubMed  CAS  Google Scholar 

  • Alema, G.: Allucinazioni da acido lisergico in cieco senza bulbi oculari. Riv. Neurol. 22, 720–733 (1952)

    PubMed  CAS  Google Scholar 

  • Alhadeff, B.W.: Les effets psychotomimétiques du LSD et de la psilocybine dans l’exploration clinique de la personnalité. Schweiz. Arch. Neurol. Neurochir. Psychiat. 92, 238–242 (1963)

    Google Scholar 

  • Anderson, E.W., Rawnsley, K.: Clinical studies of lysergic acid diethylamide. Mschr. Psychiat. Neurol. 128, 38–55 (1954)

    CAS  Google Scholar 

  • Arendsen Hein, G.W.: Treatment of the neurotic patient, resistant to the usual techniques of psychotherapy, with special reference to LSD. Top. Probl. Psychother. 4, 50–57 (1963)

    Google Scholar 

  • Arnold, O.H.: Untersuchungen zur Frage des Zusammenhangs zwischen Erlebnisvollzug und Kohlehydratstoffwechsel. Wien. Z. Nervenheilk. 10, 85–120 (1955)

    Google Scholar 

  • Arnold, O.H., Hoff, H.: Untersuchungen iiber die Wirkungsweise von Lysersäurediäthylamid. Wien. Z. Nervenheilk. 6, 129–150 (1953a)

    PubMed  CAS  Google Scholar 

  • Arnold, O.H., Hoff, H.: Körperschemastörungen bei LSD 25. Wien Z. Nervenheilk. 6, 259–274 (1953b)

    PubMed  CAS  Google Scholar 

  • Aronson, H., Klee, G.D.: Effect of lysergic acid diethylamide (LSD-25) on impulse control. J. nerv. ment. Dis. 131, 536–539 (1960)

    PubMed  CAS  Google Scholar 

  • Aronson, H., Silverstein, A.B., Klee, G.D.: Influence of lysergic acid diethylamide (LSD-25) on subjective time. Arch. gen. Psychiat. 1, 469–472 (1959)

    CAS  Google Scholar 

  • Aronson, H., Watermann, C.E., Klee, G.D.: The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention. J. clin. exp. Psychopath. 23, 17–23 (1962)

    CAS  Google Scholar 

  • Axelrod, P., Kessel, P.: Residual effects of LSD on ego functioning: an exploratory study with the Rorschach test. Psychol. Rep. 31, 547–550 (1972)

    PubMed  CAS  Google Scholar 

  • Bain, J.A.: A review of the biochemical effects in vitro of certain psychotomimetic agents. Ann. N.Y. Acad. Sci. 66, 459–467 (1957)

    PubMed  CAS  Google Scholar 

  • Baker, E.F.W.: The use of lysergic acid diethylamide (LSD) in psychotherapy. Canad. med. Ass. J. 91, 1200–1202 (1964)

    PubMed  CAS  Google Scholar 

  • Balestrieri, A.: Studies on cross tolerance with LSD-25, UML-491 and JB-336. Psychopharmacol. 1, 257–259 (1960)

    CAS  Google Scholar 

  • Balestrieri, A., Fontanari, D.: Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148. Arch. gen. Psychiat. 1, 279–282 (1959)

    CAS  Google Scholar 

  • Bambaren Vigil, C.: La prueba de Bender en la intoxication experimental con la LSD 25. Rev. Neuropsiquiat. 20, 588–607 (1957)

    Google Scholar 

  • Barendregt, J.T.: Performance on some objective tests under LSD-25. Advanc. psychosom. Med. (Basel) 1, 217–219 (1960)

    CAS  Google Scholar 

  • Barger, G.: Ergot and Ergotism. London: Gurney and Jackson 1931

    Google Scholar 

  • Barolin, G.S.: Erstes Europaisches Symposium für Psychotherapie unter LSD-25. Göttingen, November 1960. Wien. med. Wschr. 111, 466–468 (1961)

    PubMed  CAS  Google Scholar 

  • Becker, A.M.: Zur Psychopathologie der Lysergsäurediäthylamidwirkung. Wien. Z. Nervenheilk. 2, 402–440 (1949)

    Google Scholar 

  • Belleville, R.E.: MMPI score changes induced by lysergic acid diethylamide (LSD-25). J. clin. Psychol. 12, 279–282 (1956)

    PubMed  CAS  Google Scholar 

  • Belsanti, R.: Nuove ricerche in psichiatria sperimentale con la dietilamide dell’acido lisergico. Acta neurol. (Napoli) 10, 460–466 (1955)

    Google Scholar 

  • Benda, P., Orsini, F.: Etude expérimentale de l’estimation du temps sous LSD-25. Ann. méd.-psychol. 117, 550–557 (1959)

    CAS  Google Scholar 

  • Bender, L.: Theory and treatment of childhood schizophrenia. Acta paedopsychiat. 34, 298–307 (1968)

    Google Scholar 

  • Bender, L., Goldschmidt, L., Siva Sankar, D.V.: Treatment of autistic schizophrenic children with LSD-25 and UML-491. Recent Advanc. Biol. Psychiat. 4, 170–177 (1962)

    Google Scholar 

  • Bender, L., Faretra, G., Cobrinik, L.: LSD and UML treatment of hospitalized disturbed children. Recent Advanc. Biol. Psychiat. 5, 84–92 (1963)

    Google Scholar 

  • Benedetti, G.: Beispiel einer strukturanalytischen und pharmakodynamischen Untersuchung an einem Fall von Alkoholhalluzinose, Charakterneurose and psychoreaktiver Halluzinose. Z. Psychother. med. Psychol. 1, 177–192 (1951)

    PubMed  CAS  Google Scholar 

  • Bente, D., Itil, T., Schmid, E.E.: Elektroencephalographische Studien zur Wirkungsweise des LSD 25. Psychiat. et Neurol. (Basel) 135, 273–284 (1958)

    CAS  Google Scholar 

  • Bercel, N.A., Travis, L.E., Olinger, L.B., Dreikurs, E.: Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction. Arch. Neurol. Psychiat. (Chic.) 75, 588–611 (1956a)

    CAS  Google Scholar 

  • Bercel, N.A., Travis, L.E., Olinger, L.B., Dreikurs, E.: Model psychoses induced by LSD-25 in normals. II. Rorschach test findings. Arch. Neurol. Psychiat. (Chic.) 75, 612–618 (1956b)

    CAS  Google Scholar 

  • Berlin, L., Guthrie, T., Weider, A., Goodell, D., Wolff, H.G.: Studies in human cerebral function: the effects of mescaline and lysergic acid on cerebral processes pertinent to creative activity. J. nerv. ment. Dis. 122, 487–491 (1955)

    PubMed  CAS  Google Scholar 

  • Bertino, J.R., Klee, G.D., Weintraub, W.: Cholinesterase, d-lysergic acid diethylamide, and 2-bromolysergic acid diethylamide. J. clin. exp. Psychopath. 20, 218–222 (1959)

    CAS  Google Scholar 

  • Bierer, J., Browne, I.W.: An experiment with a psychiatric night hospital. Proc. roy. Soc. Med. 53, 930–932 (1960)

    PubMed  CAS  Google Scholar 

  • Boardman, W.K., Goldstone, S., Lhamon, W.T.: Effects of lysergic acid diethylamide (LSD) on the time sense of normals. Arch. Neurol. Psychiat. 78, 321–324 (1957)

    CAS  Google Scholar 

  • Bonny, H.L., Pahnke, W.N.: The use of music in psychedelic (LSD) psychotherapy. J. Music Ther. 9, 64–87 (1972)

    Google Scholar 

  • Bowen, W.T., Soskin, R.A., Chotlos, J.W.: Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism. A follow-up study. J. nerv. ment. Dis. 150, 111–118 (1970)

    PubMed  CAS  Google Scholar 

  • Brengelmann, J.C.: Effects of LSD-25 on test of personality. J. ment. Sci. 104, 1226–1236 (1958)

    PubMed  CAS  Google Scholar 

  • Brengelmann, J.C., Laverty, S.G., Lewis, D.J.: Differential effects of lysergic acid and sodium amytal on immediate memory and expressive movement. J. ment. Sci. 104, 144–152 (1958a)

    PubMed  CAS  Google Scholar 

  • Brengelmann, J.C., Pare, C.M.B., Sandler, M.: Alleviation of the psychological effects of LSD in man by 5-hydroxytryptophan. J. ment. Sci. 104, 1237–1244 (1958b)

    PubMed  CAS  Google Scholar 

  • Brown, F.C.: Hallucinogenic Drugs. Springfield, Illinois: Charles C. Thomas 1972

    Google Scholar 

  • Brown, B.B., Braun, D.L., Feldman, R.G.: The pharmacologic activity of (4-piperidyl) benzhydrol hydrochloride (azacyclonol hydrochloride) an ataraxic agent. J. Pharmacol. exp. Ther. 118, 153–161 (1956)

    PubMed  CAS  Google Scholar 

  • Busch, A.K., Johnson, W.C.: L.S.D. 25 as an aid in psychotherapy. (Preliminary report of a new drug). Dis. nerv. Syst. 11, 241–243 (1950)

    PubMed  CAS  Google Scholar 

  • Carlson, V.R.: Effect of lysergic acid diethylamide (LSD-25) on the absolute visual threshold. J. comp. Physiol. Psychol. 51, 528–531 (1958)

    PubMed  CAS  Google Scholar 

  • Cerletti, A.: Lysergic acid diethylamide (LSD) and related compounds. In: Neuropharmacology. Transactions of the second conference, May 25–27, 1955, Princeton, N.J., Abramson, H.A. (ed.), pp. 9–84. New York: Josiah Macy, Jr., Foundation 1956

    Google Scholar 

  • Cerletti, A.: The LSD psychosis. I. Pharmacological aspects of the LSD psychosis. In: Chemical Concepts of Psychosis. Rinkel, M., Denber, H. (eds.), pp. 63–74. New York: McDowell Obolensky 1958

    Google Scholar 

  • Cerletti, A., Doepfner, W.: Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids. J. Pharmacol. exp. Ther. 122, 124–136 (1958a)

    PubMed  CAS  Google Scholar 

  • Cerletti, A., Doepfner, W.: Spezifische Steigerung der serotonin-antagonistischen Wirkung von Lysergsäurederivaten durch Methylierung des Indolstickstoffes der Lysergsäure. Helv. physiol. pharmacol. Acta 16, C55–C57 (1958b)

    Google Scholar 

  • Cerletti, A., Rothlin, E.: Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature (Lond.) 176, 785–786 (1955)

    CAS  Google Scholar 

  • Chandler, A.L., Hartman, M.A.: Lysergic acid diethylamide (LSD-25) as a facilitating agent in psychotherapy. Arch. gen. Psychiat. 2, 286–299 (1960)

    Google Scholar 

  • Cholden, L.S., Kurland, A., Savage, C.: Clinical reactions and tolerance to LSD in chronic schizophrenia. J. nerv. ment. Dis. 122, 211–221 (1955)

    PubMed  CAS  Google Scholar 

  • Chwelos, N., Blewett, D.B., Smith, C.M., Hoffer, A.: Use of d-lysergic acid diethylamide in the treatment of alcoholism. Quart. J. Stud. Alcohol. 20, 577–590 (1959)

    PubMed  CAS  Google Scholar 

  • Clark, L.D.: Further studies of the psychological effects of Frenquel and a critical review of previous reports. J. nerv. ment. Dis. 123, 557–560 (1956)

    PubMed  CAS  Google Scholar 

  • Clark, L.D., Clark, L.S.: The effects of cortisone on LSD-25 intoxication in schizophrenic patients. J. nerv. ment. Dis. 123, 561–562 (1956)

    PubMed  CAS  Google Scholar 

  • Clark, L.C., Fox, R.P., Benington, F., Morin, R.: Effect of mescaline, lysergic acid diethylamide, and related compounds on respiratory enzyme activity of brain homogenates. Fed. Proc. 13, 27 (1954)

    Google Scholar 

  • Clark, L.C., Fox, R.P., Morin, R., Benington, F.: Effects of psychotomimetic compounds on certain oxidative and hydrolytic enzymes in mammalian brain. J. nerv. ment. Dis. 124, 466–472 (1956)

    PubMed  CAS  Google Scholar 

  • Cohen, S.: Lysergic acid diethylamide: side effects and complications. J. nerv. ment. Dis. 130, 30–40 (1960)

    PubMed  CAS  Google Scholar 

  • Cohen, S.: LSD and the anguish of dying. Harpers Magazine 231, 69–72, 77–78 (1965)

    Google Scholar 

  • Cohen, S.: A classification of LSD complications. Psychosomatics 7, 182–186 (1966)

    PubMed  CAS  Google Scholar 

  • Cohen, S.: Suicide or accident? Amer. J. Psychiat. 124, 111 (1967)

    Google Scholar 

  • Cohen, S.: The psychotomimetic agents. In: Progress in Drug Research. Jucker, E. (ed.), Vol. XV. pp. 68–102, Basel-Stuttgart: Birkhäuser 1971

    Google Scholar 

  • Cohen, S., Ditman, K.S.: Complications associated with lysergic acid diethylamide (LSD-25). J. Am. med. Ass. 181, 161–162 (1962)

    CAS  Google Scholar 

  • Cohen, S., Eisner, B.G.: Use of lysergic acid diethylamide in a psychotherapeutic setting. Arch. Neurol. Psychiat. (Chic.) 81, 615–619 (1959)

    CAS  Google Scholar 

  • Cohen, S., Fichman, L., Eisner, B.G.: Subjective reports of lysergic acid experiences in a context of psychological test performance. Amer. J. Psychiat. 115, 30–35 (1958)

    PubMed  CAS  Google Scholar 

  • Cohen, B.D., Rosenbaum, G., Luby, E.D. Gottlieb, J.S.: Comparison of phencyclidine hydrochloride (sernyl) with other drugs. Arch. gen. Psychiat. 6, 395–401 (1962)

    PubMed  CAS  Google Scholar 

  • Condrau, G.: Klinische Erfahrungen an Geisteskranken mit Lysergsäure-diäthylamid. Acta psychiat. neurol. scand. 24, 9–32 (1949)

    Google Scholar 

  • Delay, J., Pichot, P., Lainé, B., Perse, J.: Les modifications de la personnalité produites par la diéthylamide de l’acide lysergique (LSD-25). Ann. méd.-psychol. 112 (II), 1–13 (1954)

    CAS  Google Scholar 

  • Denson, R.: Complications of therapy with lysergide. Canad. med. Ass. J. 101, 659–663 (1969)

    Google Scholar 

  • Denson, R., Sydiaha, D.: A controlled study of LSD treatment in alcoholism and neurosis. Brit. J. Psychiat. 116, 443–445 (1970)

    PubMed  CAS  Google Scholar 

  • De Shon, H.J., Rinkel, M., Solomon, H.C.: Mental changes experimentally produced by L.S.D. (d-lysergic acid diethylamide tartrate). Psychiat. Quart. 26, 33–53 (1952)

    Google Scholar 

  • Doepfner, W., Cerletti, A.: Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat’s paw by serotonin. Int. Arch. Allergy 12, 89–97 (1958)

    PubMed  CAS  Google Scholar 

  • Editorial: Diazepam for LSD intoxication. Int. Drug Ther. Newslett. 6, 31 (1971)

    Google Scholar 

  • Edwards, A.E., Cohen, S.: Visual illusion, tactile sensibility and reaction time under LSD-25. Psychopharmacologia (Bed.) 2, 297–303 (1961)

    CAS  Google Scholar 

  • Eisner, B.G.: Notes on the use of drugs to facilitate group psychotherapy. Psychiat. Quart. 38, 310–328 (1964)

    PubMed  CAS  Google Scholar 

  • Eisner, B.G., Cohen, S.: Psychotherapy with lysergic acid diethylamide. J. nerv. ment. Dis. 127, 528–539 (1958)

    PubMed  CAS  Google Scholar 

  • Elmadjian, F., Hope, J.M., Lamson, E.T.: Excretion of epinephrine and norepinephrine in various emotional states. J. clin. Endocr. 17, 608–620 (1957)

    PubMed  CAS  Google Scholar 

  • Evans, F.T.: The effect of several psychotomimetic drugs on human serum cholinesterase. Psychopharmacologia (Bed.) 1, 231–240 (1960)

    CAS  Google Scholar 

  • Fabing, H.D.: Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis. Neurology (Minneap.) 5, 319–328 (1955)

    CAS  Google Scholar 

  • Fink, M., Jaffe, J. Kahn, R.L.: Drug induced changes in interview patterns: linguistic and neurophysiologic indices. In: The Dynamics of Psychiatric Drug Therapy. Sarwer-Foner, G.J. (ed.), pp. 29–44. Springfield, Illinois: Charles C. Thomas 1960

    Google Scholar 

  • Fischer, R. Georgi, F., Weber, R.: Psychophysische Korrelationen. Modellversuche zum Schizophrenieproblem. Lysergsäurediäthylamid und Mezcalin. Schweiz. med. Wschr. 81, 817–838 (1951)

    PubMed  CAS  Google Scholar 

  • Fisher, S., Cleveland, S.E.: Right-left body reactivity patterns in disorganized states. J. nerv. ment. Dis. 128, 396–400 (1959)

    PubMed  CAS  Google Scholar 

  • Foldes, V., Zsigmond, E.K., Erdos, E.G., Foldes, F.F.: Histochemical demonstration of the inhibitory effect of d-lysergic acid diethylamide (LSD) and its congeners on brain cholinesterases. Fed. Proc. 18, 389 (1959)

    Google Scholar 

  • Fontana, A.E.: El uso clínico de las drogas alucinógenas. Acta neuropsiquiat. argent. 7, 94–98 (1961)

    Google Scholar 

  • Fontana, A.E., Alvarez de Toledo, L.G.: Psicoterapia de grupo y dietilamida del ácido lisérgico. Nuevas aportaciones. Acta neuropsiquiat. argent. 6, 68–71 (1960)

    Google Scholar 

  • Forrer, G.R., Goldner, R.D.: Experimental physiological studies with lysergic acid diethylamide (LSD-25). Arch. Neurol. Psychiat. (Chic.) 65, 581–588 (1951)

    CAS  Google Scholar 

  • Frederking, W.: Über die Verwendung von Rauschdrogen (Meskalin und Lysergsäurediaethylamid) in der Psychotherapie. Psyche 7, 342–364 (1953/54)

    PubMed  CAS  Google Scholar 

  • Freedman, A.M., Ebin, E.V., Wilson, E.A.: Autistic schizophrenic children. An experiment in the use of d-lysergic acid diethylamide (LSD-25). Arch. gen. Psychiat. 6, 203–213 (1962)

    PubMed  CAS  Google Scholar 

  • Freedman, D.X.: On the use and abuse of LSD. Arch. gen. Psychiat. 18, 330–347 (1968)

    PubMed  CAS  Google Scholar 

  • Fried, G.H., Antopol, W.: The effects of psychotomimetic compounds on human cholinesterase. Anat. Rec. 125, 610 (1956)

    Google Scholar 

  • Fried, G.H., Antopol, W.: Effects of psychotomimetic compounds on human pseudocholinesterase. J. appl. Physiol. 11, 25–28 (1957)

    PubMed  CAS  Google Scholar 

  • Friedman, S.A., Hirsch, S.E.: Extreme hyperthermia after LSD ingestion. J. Amer. med. Ass. 217, 1549–1550 (1971)

    CAS  Google Scholar 

  • Frosch, W.A., Robbins, E.S., Stern, M.: Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization. New Engl. J. Med. 273, 1235–1239 (1965)

    PubMed  CAS  Google Scholar 

  • Gastaut, H., Ferrer, S., Castells, C., Lesevre, N., Luschnat, K.: Action de la diéthylamide de l’acide d-lysergique (LSD-25) sur les fonctions psychiques et l’électroencéphalogramme. Confin. neurol. (Basel) 13, 102–120 (1953)

    CAS  Google Scholar 

  • Geert-Jörgensen, E., Hertz, M., Knudsen, K., Kristensen, K.: LSD-treatment. Experience gained within a three-year-period. Acta psychiat. scand. 40 (Suppl. 180), 373–382 (1964)

    Google Scholar 

  • Geronimus, L.H., Abramson, H.A., Ingraham, L.J.: Lysergic acid diethylamide (LSD-25): XXIII. Comparative effects of LSD-25 and related ergot drugs on brain tissue respiration and on human behavior. J. Psychol. 42, 157–168 (1956)

    CAS  Google Scholar 

  • Giberti, F., Gregoretti, L.: Prime esperienze di antagonismo psicofarmacologico. Psicosi sperimentale da LSD e trattamento con cloropromazina e reserpina. Sist. nerv. 7, 301–310 (1955)

    PubMed  CAS  Google Scholar 

  • Giberti, F., Gregoretti, L.: Studio comparativo degli effetti psicopatologici della monoetilamide dell’acido lisergico (L.A.E.32) e della dietilamide dell’acido lisergico (L.S.D.25) in soggetti neurotici. Sist. nerv. 10, 97–110 (1958)

    PubMed  CAS  Google Scholar 

  • Giberti, F., Gregoretti, L. Boeri, G.: L’impiego della dietilamide dell’acido lisergico nelle psiconevrosi. Considerazioni e principii preliminari di valutazione diagnostico-terapeutica. Sist. nerv. 8, 191–208 (1956)

    PubMed  CAS  Google Scholar 

  • Ginzel, K.H., Mayer-Gross, W.: Prevention of psychological effects of d-lysergic acid diethylamide (LSD-25) by its 2-brom derivative (BOL 148). Nature (Lond.) 178, 210 (1956)

    CAS  Google Scholar 

  • Gogerty, J.H., Dille, J.M.: Pharmacology of d-lysergic acid morpholide (LSM). J. Pharmacol. exp. Ther. 120, 340–348 (1957)

    PubMed  CAS  Google Scholar 

  • Gomirato, G., Gamna, G., Pascal, E.: Il disegno dell’albero applicato allo studio delle modificazioni pricopatologiche indotte dalla dietilamide dell’acido d-lisergico in schizofrenici. G. Psichiat. Neuropat. 86, 433–483 (1958)

    PubMed  CAS  Google Scholar 

  • Gorodetzky, C.W., Isbell, H.: A comparison of 2,3-dihydrolyscrgic acid diethylamide with LSD-25. Psychopharmacologia (Bed.) 6, 229–233 (1964)

    CAS  Google Scholar 

  • Graham, J.R.: Methysergide for prevention of headache. Experience in five hundred patients over three years. New Engl. J. Med. 270, 67–72 (1964)

    PubMed  CAS  Google Scholar 

  • Grof, S., Dytrych, Z.: Blocking of LSD reaction by premedication with niamid. Activ. nerv. sup. (Praha) 7, 306 (1965)

    CAS  Google Scholar 

  • Grof, S., Goodman, L.E., Richards, W.A., Kurland, A.A.: LSD-assisted psychotherapy in patients with terminal cancer. Int. Pharmacopsychiat. 8, 129–144 (1973)

    CAS  Google Scholar 

  • Hale, A.R., Reed, A.F.: Prophylaxis of frequent vascular headache with methysergide. Amer. J. med. Sci. 243, 92–98 (1962)

    PubMed  CAS  Google Scholar 

  • Haley, T.J.: 5-hydroxytryptamine antagonism by lysergic acid diethylamide after intracerebral injection in conscious mice. J. Am. pharm. Ass. 46, 428–430 (1957)

    CAS  Google Scholar 

  • Harding, T.: The effect of lysergic acid diethylamide on serum creatine kinase levels. Psychopharmacologia (Bed.) 40, 177–184 (1974)

    CAS  Google Scholar 

  • Heim, E., Heimann, H., Lukacs, G.: Die psychische Wirkung der mexikanischen Droge „Ololiuqui“ am Menschen. Psychopharmacologia (Berl.) 13, 35–48 (1968)

    CAS  Google Scholar 

  • Heimann, H.: Die Wirkung von Ololiuqui im Unterschied zu Psilocybin. Neuropsychopharm. 4. 474–477 (1965)

    Google Scholar 

  • Henkin, R., Buchsbaum, M., Welpton, D., Zahn, T., Scott, W., Wynne, L., Silverman, J.: Physiological and psychological effects of LSD in chronic users. Clin. Res. 15, 484 (1967)

    Google Scholar 

  • Hirsch, M.W., Jarvik, M.E., Abramson, H.A.: Lysergic acid diethylamide (LSD-25): XVIII. Effects of LSD-25 and six related drugs upon handwriting. J. Psychol. 41, 11–22 (1956)

    Google Scholar 

  • Hoagland, H., Rinkel, M. Hyde, R.W.: Adrenocortical function and urinary phosphate excretion. Comparison in schizophrenia and in lysergic acid diethylamide-induced psychotic episodes in normal persons. Arch. Neurol. Psychiat. 73, 100–109 (1955)

    CAS  Google Scholar 

  • Hoch, P.: Studies in routes of administration and counteracting drugs. In: Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry. Cholden, L. (ed.), pp. 8–12. New York-London: Grune and Stratton 1956a

    Google Scholar 

  • Hoch, P.H.: The production and alleviation of mental abnormalities by drugs. XXth International Physiological Congress, Brussels, July 30th–August 4th, 1956b. Abstracts of Reviews, pp. 429–442

    Google Scholar 

  • Hoch, P.H., Cattell, J.P., Pennes, H.H.: Effects of mescaline and lysergic acid (d-LSD-25). Amer. J. Psychiat. 108, 579–584 (1952)

    PubMed  CAS  Google Scholar 

  • Hoffer, A.: D-lysergic acid diethylamide (LSD): a review of its present status. Clin. Pharmacol. Ther. 2, 183–255 (1965)

    Google Scholar 

  • Hoffer, A., Osmond, H., Smythies, J.: Schizophrenia: a new approach. II. Result of a year’s research. J. ment. Sci. 100, 29–45 (1954)

    PubMed  CAS  Google Scholar 

  • Hoffer, A., Smith, C., Chwelos, N., Callbeck, M.J., Mahon, M.: Psychological response to d-lysergic acid diethylamide and its relationship to adrenochrome levels. J. clin. exp. Psychopath. 20, 125–134 (1959)

    PubMed  CAS  Google Scholar 

  • Hofmann, A.: Relationship between spatial arrangement and mental effects. In: Chemical Concepts of Psychosis. Rinkel, M., Denber, H.C.B. (eds.), pp. 85–90. New York: McDowell-Obolensky 1958

    Google Scholar 

  • Hofmann, A.: Die Wirkstoffe der mexikanischen Zauberdroge „Ololiuqui“. Planta med. (Stuttg.) 9, 354–367 (1961)

    Google Scholar 

  • Hofmann, A.: The active principles of the seeds of rivea corymbosa and ipomoea violacea. Botanical Museum Leaflets Harvard University 20, 194–212 (1963)

    CAS  Google Scholar 

  • Hofmann, A.: Die Mutterkornalkaloide. Stuttgart: Ferdinand Enke Verlag 1964

    Google Scholar 

  • Hofmann, A.: The discovery of LSD and subsequent investigations on naturally occurring hallucinogens. In: Discoveries in Biological Psychiatry. Ayd, F.J., Blackwell, B. (eds.), pp. 91–106. Philadelphia-Toronto: J.B. Lippincott 1970a

    Google Scholar 

  • Hofmann, A.: Notes and documents concerning the discovery of LSD. Agents Actions 1, 148–150 (1970b)

    PubMed  CAS  Google Scholar 

  • Hofmann, A., Cerletti, A.: Die Wirkstoffe der dritten aztekischen Zauberdroge. Die Lösung des „Ololiuqui“-Ratsels. Dtsch. med. Wschr. 86, 885–888 (1961)

    PubMed  CAS  Google Scholar 

  • Hofmann, A., Tscherter, H.: Isolierung von Lysergsäure-Alkaloiden aus der mexikanischen Zauberdroge Ololiuqui. Experientia (Basel) 16, 414 (1960)

    CAS  Google Scholar 

  • Horackova, E., Mosinger, B., Vojtechovsky, M.: Square test for investigating the concentration of attention in experimental psychosis evoked by diethylamide lysergic acid (LSD-25). Čs. Psychiat. 54, 236–243 (1958)

    CAS  Google Scholar 

  • Horita, A., Gogerty, J.H.: The pyretogenic effect of 5-hydroxytryptophan and its comparison with that of LSD. J. Pharmacol. exp. Ther. 122, 195–200 (1958)

    PubMed  CAS  Google Scholar 

  • Horowitz, H.A.: The use of lithium in the treatment of the drug-induced psychotic reaction. Dis. nerv. Syst. 36, 159–163 (1975)

    PubMed  CAS  Google Scholar 

  • Horowitz, M.J.: Flashbacks: recurrent intrusive images after the use of LSD. Amer. J. Psychiat. 126, 565–569 (1969)

    PubMed  CAS  Google Scholar 

  • Hurst, L.A., Reuning, H., van Wyk, A.J., Crouse, H.S., Booysen, P.J., Nelson, G.: Experiences with d-lysergic acid diethylamide (LSD). A symposium. S.A.J. Lab. clin. Med. 2, 289–310 (1956)

    Google Scholar 

  • Huxley, A.: The Doors of Perception. New York: Harper and Brothers 1954

    Google Scholar 

  • Huxley, A.: Heaven and Hell. London: Chatto and Windus 1956

    Google Scholar 

  • Isbell, H.: Effects of various drugs on the LSD reaction. In: Psychopharmacology Frontiers. Kline, N.S. (ed.), pp. 361–364. Boston-Toronto: Little, Brown 1959

    Google Scholar 

  • Isbell, H.: Personal communication 1962

    Google Scholar 

  • Isbell, H., Gorodetzky, C.W.: Effect of alkaloids of Ololiuqui in man. Psychopharmacologia (Berl.) 8, 331–339 (1966)

    CAS  Google Scholar 

  • Isbell, H., Jasinski, D.R.: A comparison of LSD-25 with (-)-Δ9-Trans-Tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC. Psychopharmacologia (Berl.) 14, 115–123 (1969)

    CAS  Google Scholar 

  • Isbell, H., Logan, C.R.: Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and reserpine on the intensity of the LSD-reaction. Arch. Neurol. Psychiat. 77, 350–358 (1957)

    CAS  Google Scholar 

  • Isbell, H., Belleville, R.E., Fraser, H.F., Wikler, A., Logan, C.R.: Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication. Arch. Neurol. Psychiat. 76, 468–478 (1956)

    Google Scholar 

  • Isbell, H., Miner, E.J., Logan, C.R.: Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25). Psychopharmacologia (Berl.) 1, 20–28 (1959a)

    CAS  Google Scholar 

  • Isbell, H., Miner, E.J., Logan, C.R.: Cross tolerance between d-2-brom-lysergic acid diethylamide (BOL-148) and the d-diethylamide of lysergic acid (LSD-25). Psychopharmacologia (Berl.) 1, 109–116 (1959b)

    CAS  Google Scholar 

  • Isbell, H., Wolbach, A.B., Wikler, A., Miner, E.J.: Cross tolerance between LSD and Psilocybin. Psychopharmacologia (Berl.) 2, 147–159 (1961)

    CAS  Google Scholar 

  • Itil, T.M., Keskiner, A., Holden, J.M.C.: The use of LSD and ditran in the treatment of therapy resistant schizophrenics. Dis. nerv. Syst. 30 (Suppl. 2), 93–103 (1969)

    PubMed  Google Scholar 

  • Jarvik, M.E., Abramson, H.A., Hirsch, M.W.: Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25). J. abnorm. soc. Psychol. 51, 657–662 (1955a)

    CAS  Google Scholar 

  • Jarvik, M.E., Abramson, H.A., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): IV. Effect on attention and concentration. J. Psychol. 39, 373–383 (1955b)

    Google Scholar 

  • Jarvik, M.E., Abramson, H.A., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): VI. Effect upon recall and recognition of various stimuli. J. Psychol. 39, 443–454 (1955c)

    Google Scholar 

  • Jarvik, M.E., Abramson, H.A., Hirsch, M.W., Ewald, A.T.: Lysergic acid diethylamide (LSD-25): VIII. Effect on arithmetic test performance. J. Psychol. 39, 465–473 (1955d)

    Google Scholar 

  • Jensen, S.E., Ramsay, R.: Treatment of chronic alcoholism with lysergic acid diethylamide. Canad. psychiat. Ass. J. 8, 182–188 (1963)

    Google Scholar 

  • Johnson, F.G.: LSD in the treatment of alcoholism. Amer. J. Psychiat. 126, 481–487 (1969)

    PubMed  CAS  Google Scholar 

  • Jost, F.: Zur therapeutischen Verwendung des LSD XXV in der klinischen Praxis der Psychiatrie. Wien. klin. Wschr. 69, 647–651 (1957)

    Google Scholar 

  • Kast, E.C.: The analgesic action of lysergic acid compared with dihydromorphinone and meperidine. Bull. Drug Addict. Narcot. Appendix 27, 3517–3529 (1963)

    Google Scholar 

  • Kast, E.: LSD and the dying patient. Chicago Med. School Quart. 26, 80–87 (1966)

    CAS  Google Scholar 

  • Kast, E.: Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide. Psychiat. Quart. 41, 646–657 (1967)

    PubMed  CAS  Google Scholar 

  • Kast, E.C., Collins, V.J.: A study of lysergic acid diethylamide as an analgesic agent. Anaesth. Analg. Curr. Res. 43, 285–291 (1964)

    CAS  Google Scholar 

  • Klee, G.D., Weintraub, W.: Paranoid reactions following lysergic acid diethylamide (LSD-25). In: Neuro-Psychopharmacology. Proc. 1st Int. Congr. Neuro-Psychopharmacology, Rome, Sept. 1958. Bradley, P.B., Deniker, P., Radouco-Thomas, C. (eds.), pp. 457–460. Amsterdam-London-New York-Princeton: Elsevier 1959

    Google Scholar 

  • Klock, J.C., Boerner, U., Becker, C.E.: Coma, hyperthermia and bleeding associated with massive LSD overdose: a report of eight cases. West. J. Med. 120 (3), 183–188 (1974)

    PubMed  CAS  Google Scholar 

  • Knudsen, K.: Homicide after treatment with lysergic acid diethylamide. Acta psychiat. scand. 40 (Suppl. 180), 389–395 (1964)

    PubMed  Google Scholar 

  • Kornetsky, C., Humphries, O.: Relationship between effects of a number of centrally acting drugs and personality. Arch. Neurol. Psychiat. (Chic.) 77, 325–327 (1957)

    CAS  Google Scholar 

  • Kornetzsky, C., Humphries, O., Evarts, E.V.: Comparison of psychological effects of certain centrally acting drugs in man. Arch. Neurol. Psychiat. (Chic.) 77, 318–324 (1957)

    Google Scholar 

  • Krill, A.E., Wieland, A.M., Ostfeld, A.M.: The effect of two hallucinogenic agents on human retinal function. Arch. Ophthal. 64, 724–733 (1960)

    PubMed  CAS  Google Scholar 

  • Krill, A.E., Alpert, H.J., Ostfeld, A.M.: Effects of a hallucinogenic agent in totally blind subjects. Arch. Ophthal. 69, 180–185 (1963)

    PubMed  CAS  Google Scholar 

  • Krus, D.M., Wapner, S.: Effect of lysergic acid diethylamide (LSD-25) on perception of part-whole relationships. J. Psychol. 48, 87–95 (1959)

    Google Scholar 

  • Krus, D.M., Wapner, S., Bergen, J., Freeman, H.: The influence of progesterone on behavioral changes induced by lysergic acid diethylamide (LSD-25) in normal males. Psychopharmacologia (Bed.) 2, 177–184 (1961)

    CAS  Google Scholar 

  • Krus, D.M., Resnick, O., Raskin, M.: Apparent eye level test. Its background and use in psychopharmacology. Arch. gen. Psychiat. 14, 419–427 (1966)

    PubMed  CAS  Google Scholar 

  • Kurland, A.A., Unger, S., Shaffer, J.W., Savage, C.: Psychedelic therapy utilizing LSD in the treatment of the alcoholic patient: a preliminary report. Amer. J. Psychiat. 123, 1202–1209 (1967)

    PubMed  CAS  Google Scholar 

  • Kurland, A.A., Savage, C., Unger, S.: LSD in psychiatric treatment. Clin. Psychopharmacol. Mod. Probl. Pharmacopsychiat. 1, 273–284 (1968)

    Google Scholar 

  • Kurland, A.A., Savage, C., Pahnke, W.N., Grof, S., Olsson, J.E.: LSD in the treatment of alcoholics. Pharmakopsychiatr. Neuropsychopharmakol. 4, 83–94 (1971)

    Google Scholar 

  • Kurland, A.A., Grof, S., Pahnke, W.N., Goodman, L.E.: Psychedelic drug assisted psychotherapy in patients with terminal cancer. In: Psychopharmacological Agents for the Terminally Ill and Bereaved. Goldberg, I.K., Malitz, S., Kutscher, A.H. (eds.), pp. 86–133. New York-London: Columbia Univ. Press 1973

    Google Scholar 

  • Landis, C., Clausen, J.: Certain effects of mescaline and lysergic acid on psychological functions. J. Psychol. 38, 211–221 (1954)

    Google Scholar 

  • Langs, R.J., Barr, H.L.: Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. J. nerv. ment. Dis. 147, 163–172 (1968)

    PubMed  CAS  Google Scholar 

  • Leary, T.: The religious experience: its production and interpretation. Psychedelic Rev. 1, 324–346 (1964)

    Google Scholar 

  • Leary, T., Alpert, R.: The politics of consciousness expansion. Harvard Rev. 1, 33–37 (1963)

    Google Scholar 

  • Lebovits, B.Z., Visotsky, H.M., Ostfeld, A.M.: LSD and JB 318: a comparison of two hallucinogens. I. An exploratory study. Arch. gen. Psychiat. 2, 390–407 (1960a)

    CAS  Google Scholar 

  • Lebovits, B.Z., Visotsky, H.M., Ostfeld, A.M.: Lysergic acid diethylamide (LSD) and JB 318: a comparison of two hallucinogens. II. An exploratory study. Arch. gen. Psychiat. 3, 176–187 (1960b)

    PubMed  CAS  Google Scholar 

  • Lebovits, B.Z., Visotsky, H.M., Ostfeld, A.M.: LSD and JB 318: a comparison of two hallucinogens. III. Qualitative analysis and summary of findings. Arch. gen. Psychiat. 7, 39–45 (1962)

    PubMed  CAS  Google Scholar 

  • Lesse, S.: Psychodynamic relationships between the degree of anxiety and other clinical symptoms. J. nerv. ment. Dis. 127, 124–130 (1958)

    PubMed  CAS  Google Scholar 

  • Lesse, S.: Discussion on drug research. In: IInd International Congress for Psychiatry. Congress Report: Vol. II, pp. 324–325. Zürich: Orell Füssli 1959

    Google Scholar 

  • Leuner, H.: Die experimentelle Psychose. Berlin-Güttingen-Heidelberg: Springer 1962

    Google Scholar 

  • Leuner, H.: Die Psycholytische Therapie: klinische Psychotherapie mit Hilfe von LSD-25 und verwandten Substanzen. Z. Psychother. med. Psychol. 13, 57–64 (1963a)

    PubMed  CAS  Google Scholar 

  • Leuner, H.: Psychotherapy with hallucinogens. A clinical report with special reference to the revival of emotional phases of childhood. In: Proc. Quart. Meet. Royal Med. Psychol. Assoc., London, February 1961, pp. 67–73. London: H.K. Lewis 1963b

    Google Scholar 

  • Leuner, H.: Über den Rauschmittelmißbrauch Jugendlicher. Nervenarzt 42, 281–291 (1971a)

    PubMed  CAS  Google Scholar 

  • Leuner, H.: Halluzinogene in der Psychotherapie. Pharmakopsychiatr. Neuropsychopharmakol. 4, 333–351 (1971b)

    Google Scholar 

  • Leuner, H., Holfeld, H.: Ergebnisse und Probleme der Psychotherapie mit Hilfe von LSD-25 und verwandten Substanzen. Psychiat. et Neurol. (Basel) 143, 379–391 (1962)

    CAS  Google Scholar 

  • Levine, A., Abramson, H.A., Kaufman, M.R., Markham, S.: Lysergic acid diethylamide (LSD-25): XVI. The effect on intellectual functioning as measured by the Wechsler-Bellevue intelligence scale. J. Psychol. 40, 385–395 (1955a)

    Google Scholar 

  • Levine, A., Abramson, H.A., Kaufman, M.R., Markham, S., Kornetsky, C.: Lysergic acid diethylamide (LSD-25): XIV. Effect on personality as observed in psychological tests. J. Psychol. 40, 351–366 (1955b)

    Google Scholar 

  • Levy, R.M.: Diazepam for LSD intoxication. Lancet 1971 I, 1297

    Google Scholar 

  • Lewis, D.J., Sloane, R.B.: Therapy with lysergic acid diethylamide. J. clin. exp. Psychopath. 19, 19–31 (1958)

    PubMed  CAS  Google Scholar 

  • Liddell, D.W., Weil-Malherbe, H.: The effects of methedrine and of lysergic acid diethylamide on mental processes and on the blood adrenaline level. J. Neurol. Neurosurg. Psychiat. 16, 7–13 (1953)

    PubMed  CAS  Google Scholar 

  • Liebert, R.S., Werner, H., Wapner, S.: Studies in the effect of lysergic acid diethylamide (LSD-25). Self-and object-size perception in schizophrenics and normal adults. Arch. Neurol. Psychiat. (Chic.) 79, 580–584 (1958)

    CAS  Google Scholar 

  • Lienert, G.A.: Pharmakopsychologische Untersuchungen uber den Abbau der geistigen Leistungsfähigkeit. Bericht über den 20. Kongreß der Deutschen Gesellschaft für Psychologie, Berlin, 1955, pp. 144–147. Göttingen: Verlag für Psychologie (Dr. C.J. Hogrefe) 1956

    Google Scholar 

  • Lienert, G.A.: Über eigenartige Motivationsvorgänge unter Wirkung von Lysergsäure-Diäthylamid. Bericht über den 21. Kongreß der Deutschen Gesellschaft für Psychologie, Bonn, 1957, pp. 202–205. Göttingen: Verlag für Psychologie (Dr. C.J. Hogrefe) 1958

    Google Scholar 

  • Lienert, G.A.: Changes in the factor structure of intelligence tests produced by d-lysergic acid diethylamide (LSD). In: Neuro-Psychopharmacology. Proc. 1st Int. Congr. Neuro-Psychopharmacology, Rome, Sept. 1958. Bradley, P.B., Deniker, P., Radouco-Thomas, C. (eds.), pp. 461–465. Amsterdam-London-New York-Princeton: Elsevier 1959

    Google Scholar 

  • Lienert, G.A.: Die Farbwahl im Farbpyramidentest unter Lysergsäurediätylamid (LSD). Versuch einer experimentellen Prüfung klinischer Gültigkeitshypothesen. Z. exp. angew. Psychol. 8, 110–121 (1961)

    Google Scholar 

  • Ling, T.M., Buckman, J.: The use of lysergic acid in individual psychotherapy. Proc. roy. Soc. Med. 53, 927–929 (1960)

    PubMed  CAS  Google Scholar 

  • Ling, T.M., Buckman, J.: Lysergic acid (LSD 25) and Ritalin in the treatment of neurosis. London: The Lambarde Press 1963

    Google Scholar 

  • Linken, A.: Propranolol for LSD-induced anxiety states. Lancet 1971II, 1039–1040

    Google Scholar 

  • Linton, H.B., Langs, R.J.: Subjective reactions to lysergic acid diethylamide (LSD-25). Measured by a questionnaire. Arch. gen. Psychiat. 6, 352–368 (1962)

    Google Scholar 

  • Loeb, C., Giberti, F.: Lysergic acid diethylamide effects modified by hydroxyzine hydrochloride. Confin. neurol. (Basel) 19, 40–51 (1959)

    CAS  Google Scholar 

  • Louria, D.B.: Lysergic acid diethylamide. New Engl. J. Med. 278, 435–438 (1968)

    PubMed  CAS  Google Scholar 

  • Ludwig, A.M., Levine, J.: Patterns of hallucinogenic drug abuse. J. Amer. med. Ass. 191, 92–96 (1965a)

    CAS  Google Scholar 

  • Ludwig, A.M., Levine, J.: A controlled comparison of five brief treatment techniques employing LSD, hypnosis and psychotherapy. Amer. J. Psychother. 19, 417–435 (1965b)

    PubMed  CAS  Google Scholar 

  • Ludwig, A., Levine, J., Stark, L., Lazar, R.: A clinical study of LSD treatment in alcoholism. Amer. J. Psychiat. 126, 59–69 (1969)

    PubMed  CAS  Google Scholar 

  • Ludwig, A.M., Levine, J., Stark, L.H.: LSD and Alcoholism. A clinical study of treatment efficacy. Springfield, Illinois: Charles C. Thomas 1970

    Google Scholar 

  • Maccagnani, G., Bobon, J., Goffioul, F.: Exploration sous psychodysleptiques du contenu latent de dessins schizophréniques stéréotypés. Encéphale 53, 543–552 (1964)

    PubMed  CAS  Google Scholar 

  • McGlothlin, W., Cohen, S., McGlothlin, M.S.: Long lasting effects of LSD on normals. Arch. gen. Psychiat. 17, 521–532 (1967)

    PubMed  CAS  Google Scholar 

  • McGlothlin, W.H., Arnold, D.O., Freedman, D.X.: Organicity measures following repeated LSD ingestion. Arch. gen. Psychiat. 21, 704–709 (1969)

    PubMed  CAS  Google Scholar 

  • McGlothlin, W.H., Arnold, D.O.: LSD revisited. A ten-year follow-up of medical LSD use. Arch. gen. Psychiat. 24, 35–49 (1971)

    PubMed  CAS  Google Scholar 

  • Machover, K., Liebert, R.: Human figure drawings of schizophrenic and normal adults. Changes following administration of lysergic acid. Arch. gen. Psychiat. 3, 139–152 (1960)

    PubMed  CAS  Google Scholar 

  • Malitz, S., Wilkens, B., Roehrig, W.C., Hoch, P.H.: A clinical comparison of three related hallucinogens. Psychiat. Quart. 34, 333–345 (1960)

    PubMed  CAS  Google Scholar 

  • Malitz, S., Wilkens, B., Esecover, H.: A comparison of drug-induced hallucinations with those seen in spontaneously occurring psychoses. In: Hallucinations. West, C.J. (ed.), pp. 50–63. New York-London: Grune and Stratton 1962

    Google Scholar 

  • Manger, W.M., Schwarz, B.E., Baars, C.W., Wakim, K.G., Boliman, J.L., Petersen, M.C., Berkson, J.: Plasma and cerebrospinal fluid concentrations of epinephrine and norepinephrine in certain psychiatric conditons. XXth International Physiological Congress, Brussels 1956. Abstracts of Communications, p. 610

    Google Scholar 

  • Martin, A.J.: L.S.D. (Lysergic acid diethylamide) treatment of chronic psychoneurotic patients under day-hospital conditions. Int. J. soc. Psychiat. 3, 188–195 (1957)

    Google Scholar 

  • Martin, A.J.: The treatment of twelve male homosexuals with L.S.D. (followed by a detailed account of one of them who was a psychopathic personality). Acta psychother. 10, 394–402 (1962)

    Google Scholar 

  • Matefi, L.: Mezcalin-und Lysergsäurediäthylamid-Rausch. Selbstversuche mit besonderer Berücksichtigung eines Zeichentests. Confin. neurol. (Basel) 12, 146–177 (1952)

    CAS  Google Scholar 

  • Mayer-Gross, W., McAdam, W., Walker, J.: Lysergsäure-Diäthylamid und Kohlenhydratstoffwechsel. Vorläufige Mitteilung. Nervenarzt 23, 30–31 (1952)

    CAS  Google Scholar 

  • Mayer-Gross, W., McAdam, W., Walker, J.W.: Further observations on the effects of lysergic acid diethylamide. J. ment. Sci. 99, 804–808 (1953)

    PubMed  CAS  Google Scholar 

  • Meltzer, H.: Creatine kinase and aldolase in serum; abnormality common to acute psychoses. Science 159, 1368–1370 (1968)

    PubMed  CAS  Google Scholar 

  • Meltzer, H.Y.: Plasma creatine phosphokinase levels in rats following lysergic acid diethylamide. Psychopharmacologia (Berl.) 44, 91–93 (1975)

    CAS  Google Scholar 

  • Miller, A.L., Williams, H.L., Murphree, H.P.: Niacin, niacinamide, or atropine versus LSD-25 model psychoses in human volunteers. J. Pharmacol. exp. Ther. 119, 169 (1957)

    Google Scholar 

  • Milman, D.H.: An untoward reaction to accidental ingestion of LSD in a 5-year-old girl. J. Am. med. Ass. 201, 821–824 (1967)

    CAS  Google Scholar 

  • Monroe, R.R., Heath, R.G., Mickle, W.A., Llewellyn, R.C.: Correlation of rhinencephalic electrograms with behavior. A study on humans under the influence of LSD and mescaline. EEG Clin. Neurophysiol. 9, 623–642 (1957)

    CAS  Google Scholar 

  • Murphree, H.B., de Maar, E.W.J., Williams, H.L., Bryan, L.L.: Effects of lysergic acid derivatives on man; antagonism between d-lysergic acid diethylamide and its 2-brom congener. J. Pharmacol. exp. Ther. 122, 55A (1958)

    Google Scholar 

  • O’Reilly, P.O., Reich, G.: Lysergic acid and the alcoholic. Dis. nerv. Syst. 23, 331–334 (1962)

    PubMed  Google Scholar 

  • Orsini, F., Benda, P.: Etude expérimentale du ralentissement de la performance sous LSD-25. Ann. méd.-psychol. 117, 519–525 (1959)

    Google Scholar 

  • Orsini, F., Benda, P.: L’épreuve du dessin en miroir sous LSD-25. Ann. méd.-psychol. 118, 809–816 (1960)

    Google Scholar 

  • Osmond, H.: Ololiuqui: the ancient aztec narcotic. Remarks on the effects of rivea corymbosa (Ololiuqui). J. ment. Sci. 101, 526–537 (1955)

    PubMed  CAS  Google Scholar 

  • Osmond, H.: Research on schizophrenia. In: Neuropharmacology. Transactions of the second conference, Princeton, N.J., May 25–27, 1955. Abramson, H.A. (ed.), pp. 183–233. New York: Josiah Macy, Jr., Foundation 1956

    Google Scholar 

  • Osmond, H.: A review of the clinical effects of psychotomimetic agents. Ann. N.Y. Acad. Sci. 66, 418–434 (1958)

    Google Scholar 

  • Pahnke, W.H., Kurland, A.A., Goodman, L.E., Richards, W.A.: LSD-assisted psychotherapy with terminal cancer patients. In: Psychedelic Drugs. Proceedings of a Hahnemann Medical College and Hospital Symposium, Philadelphia, Nov. 22–24, 1968. Hicks, R.E., Fink, P.J. (eds.), pp. 33–42. New York-London: Grune and Stratton 1969

    Google Scholar 

  • Pauk, Z.D., Shagass, C.: Some test findings associated with susceptibility to psychosis induced by lysergic acid diethylamide. Comprehens. Psychiat. 2, 188–195 (1961)

    CAS  Google Scholar 

  • Pérez Morales, F.: El LSD 25 en psicoterapia. Su fundamentación histórica y metodológica. Acta psiquiát. psicol. argent. 9, 33–39 (1963a)

    Google Scholar 

  • Pérez Morales, F.: El LSD 25 en la psicoterapia. Psicoterapia individual. Acta psiquiát. psicol. argent. 9, 136–143 (1963b)

    Google Scholar 

  • Pérez Morales, F.: Psicoterapia y LSD 25 (III). Acta psiquiát. psicol. argent. 9, 226–232 (1963c)

    Google Scholar 

  • Perillo, A.E., Garcia de la Villa, A.: Experiencia farmacológica en el discutido terreno de la demencia esquizofrénica. Acta psiquiát. psicol. argent. 9, 49–52 (1963)

    Google Scholar 

  • Pfeiffer, C.C., Goldstein, L., Murphree, H.B., Sugerman, A.: Time-series, frequency analysis, and electrogenesis of the EEGs of normals and psychotics before and after drugs. Amer. J. Psychiat. 121, 1147–1155 (1965)

    PubMed  CAS  Google Scholar 

  • Pierce, J.: Zur Wirkung von Atarax auf die LSD-Modellpsychose. Praxis 50, 486–491 (1961)

    PubMed  CAS  Google Scholar 

  • Poloni, A.: Serotonina e schizofrenia. Osservazioni sulle interferenze fra l’azione della serotonina (S.) e della dietilamide dell’acido lisergico (LSD-25), mescalina (M.) e bulbocapnina (B.) nell’uomo e nell’animale. Cervello 31, 271–294 (1955)

    CAS  Google Scholar 

  • Priori, R.: Esperienza interiore e linguaggio nella “model psychosis” indotta da LSD-25. Lav. neuropsichiat. 21, 209–224 (1957)

    Google Scholar 

  • Purpura, D.P., Pool, J.L., Ransohoff, J., Frumin, M.J., Housepian, E.M.: Observations on evoked dentritic potentials of human cortex. EEG Clin. Neurophysiol. 9, 453–459 (1957)

    CAS  Google Scholar 

  • Richards, N., Chapman, L.F., Goodell, H., Wolff, H.G.: LSD-like delirium following ingestion of a small amount of its brom analog (BOL-148). Ann. intern. Med. 48, 1078–1083 (1958)

    PubMed  CAS  Google Scholar 

  • Rinkel, M.: Experimentally induced psychoses in man. In: Neuropharmacology. Transactions of the second conference, Princeton, N.J., May 25–27, 1955. Abramson, H.A. (ed.), pp. 235–258. New York: Josiah Macy, Jr., Foundation 1956

    Google Scholar 

  • Rinkel, M., De Shon, H.J., Hyde, R.W., Solomon, H.C.: Experimental schizophrenia-like symptoms. Amer. J. Psychiat. 108, 572–578 (1952)

    CAS  Google Scholar 

  • Rinkel, M., Hyde, R.W., Solomon, H.C., Hoagland, H.: Experimental psychiatry II. Clinical and physio-chemical observations in experimental psychosis. Amer. J. Psychiat. 111, 881–895 (1955)

    PubMed  CAS  Google Scholar 

  • Robinson, J.T., Davies, L.S., Sack, E.L.N.S., Morrissey, J.D.: A controlled trial of abreaction with lysergic acid diethylamide (LSD 25). Brit. J. Psychiat. 109, 46–53 (1963)

    PubMed  CAS  Google Scholar 

  • Rojas Bermudez, J.G.: Tratamiento combinado de psicoanálisis y LSD 25 en niños psicóticos. Acta neuropsiquiat. argent. 6, 497–500 (1960)

    Google Scholar 

  • Rojo Sierra, M.: Terapéutica lisérgica en ciertos síndromes obsesivos y neurosis sexuales. Act. luso-esp. Neurol. 18, 108–113 (1959)

    Google Scholar 

  • Rojo Sierra, M.: El LSD 25 y la psicoterapia en grupo. Rev. Psiquiat. Psicol. méd. 4, 419–422 (1960)

    Google Scholar 

  • Rosenbaum, G., Cohen, B.D., Luby, E.D., Gottlieb, J.S., Yelen, D.: Comparison of sernyl with other drugs. Simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. Arch. gen. Psychiat. 1, 651–656 (1959)

    CAS  Google Scholar 

  • Rosenberg, D.E., Wolbach, A.B., Miner, E.J., Isbell, H.: Observations on direct and cross tolerance with LSD and d-amphetamine in man. Psychopharmacologia (Bed.) 5, 1–15 (1963)

    CAS  Google Scholar 

  • Rosenberg, D.E., Isbell, H., Miner, E.J., Logan, C.R.: The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia (Berl.) 5, 217–227 (1964)

    CAS  Google Scholar 

  • Rosenthal, S.H.: Persistent hallucinosis following repeated administration of hallucinogenic drugs. Amer. J. Psychiat. 121, 238–244 (1964)

    PubMed  CAS  Google Scholar 

  • Rothlin, E.: Pharmacology of lysergic acid diethylamide and some of its related compounds. J. Pharm. Pharmacol. 9, 569–587 (1957)

    PubMed  CAS  Google Scholar 

  • Roubicek, J.: Experimentelle psychische Störungen. Vesmir 35, 291–294 (1956)

    Google Scholar 

  • Roubicek, J.: Similarities and differences between schizophrenia and experimental psychoses. Rev. Czechoslov. Med. 4, 125–134 (1958a)

    CAS  Google Scholar 

  • Roubicek, J.: Similarities and dissimilarities between experimental psychoses and schizophrenia. Csl. Psychiat. 54, 108–115 (1958b)

    CAS  Google Scholar 

  • Roubicek, J.: Experimentálni Psychosy. Praha: Státni Zdravotnické Nakladatelství 1961

    Google Scholar 

  • Samuelsson, B.O.: LSD intoxication in a two-year-old child. Acta paediat. scand. 63, 797–798 (1974)

    PubMed  CAS  Google Scholar 

  • Sandison, R.A.: Psychological aspects of the LSD treatment of the neuroses. J. ment. Sci. 100, 508–515 (1954)

    PubMed  CAS  Google Scholar 

  • Sandison, R.A.: The role of psychotropic drugs in individual therapy. Bull. Wld. Hlth. Org. 21, 495–503 (1959a)

    CAS  Google Scholar 

  • Sandison, R.A.: Discussion fourth symposium: comparison of drug-induced and endogenous psychoses in man. In: Neuro-Psychopharmacology. Proc. 1st Int. Congr. Neuro-Psychopharmacology, Rome, Sept. 1958. Bradley, P.B., Deniker, P., Radouco-Thomas, C. (eds.), pp. 176–182. Amsterdam-London-New York-Princeton: Elsevier 1959b

    Google Scholar 

  • Sandison, R.A.: The nature of the psychological response to LSD. In: The Use of LSD in Psychotherapy. Transactions of a Conference on D-Lysergic Acid Diethylamide (LSD-25). April 22–24, 1959. Abramson, H.A. (ed.), pp. 81–149. New York: Josiah Macy, Jr., Foundation 1960

    Google Scholar 

  • Sandison, R.A.: The hallucinogenic drugs. Practitioner 200, 244–250 (1968)

    PubMed  CAS  Google Scholar 

  • Sandison, R.A., Spencer, A.M., Whitelaw, J.D.A.: The therapeutic value of lysergic acid diethylamide in mental illness. J. ment. Sci. 100, 491–507 (1954)

    PubMed  CAS  Google Scholar 

  • Sandison, R.A., Whitelaw, J.D.A.: Further studies in the therapeutic value of lysergic acid diethylamide in mental illness. J. ment. Sci. 103, 332–343 (1957)

    PubMed  CAS  Google Scholar 

  • Sandoz Research Laboratories: Pharmacologic properties and psychotogenic effects of some lysergic acid derivatives. Comparison with Delysid (LSD 25). Scientific Exhibit, Fed. Proc. 17, 682 (1958)

    Google Scholar 

  • Sandoz Research Laboratories: Unpublished data, 1959

    Google Scholar 

  • Sanguineti, I., Zapparoli, G.C., Laricchia, R.: Studio clinico-biologico delle reazioni indotte dal solfato di mescalina e dalFacido lisergico (LSD 25) in malati di mente. Riv. sper. Freniat. 80, 887–918 (1956)

    PubMed  Google Scholar 

  • Sauri, J.J., De Onorato, A.C.: Las esquizofrenias y la dietilamida del acido d-lisergico (LSD-25). I. Variaciones del estado de animo. Acta neuropsiquiat. argent. 1, 469–476 (1955)

    Google Scholar 

  • Savage, C.: Lysergic acid diethylamide (LSD-25). A clinical psychological study. Amer. J. Psychiat. 108, 896–900 (1952)

    PubMed  CAS  Google Scholar 

  • Savage, C.: The resolution and subsequent remobilization of resistance by LSD in psychotherapy. J. nerv. ment. Dis. 125, 434–437 (1957)

    PubMed  CAS  Google Scholar 

  • Savage, C.: The uses and abuses of LSD in psychotherapy. In: Third World Congress of Psychiatry, Montreal 4.–10. 6., 1961, Part II, p. 466

    Google Scholar 

  • Savage, C.: LSD, alcoholism and transcendence. J. nerv. ment. Dis. 135, 429–435 (1962)

    PubMed  CAS  Google Scholar 

  • Savage, C., McCabe, O.L.: Residential psychedelic (LSD) therapy for the narcotic addict. Arch. gen. Psychiatry 28, 808–814 (1973)

    PubMed  CAS  Google Scholar 

  • Scherbel, A.L., Harrison, J.W.: Response to serotonin and its antagonists in patients with rheumatoid arthritis and related diseases. Angiology 10, 29–33 (1959)

    PubMed  CAS  Google Scholar 

  • Schiefer, I., Bähr, G., Boiselle, I., Kiefer, B.: EEG-Veränderungen von 9 Kindern mit einer LSD-Vergiftung. Klin. Padiat. 184, 307–311 (1972)

    CAS  Google Scholar 

  • Schneckloth, R., Page, I.H., Del Greco, F., Corcoran, A.C.: Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors. Circulation 16, 523–532 (1957)

    PubMed  CAS  Google Scholar 

  • Schwarz, B.E., Bickford, R.G., Rome, H.P.: Reversibility of induced psychosis with chlorpromazine. Proc. Mayo Clin. 30, 407–417 (1955)

    CAS  Google Scholar 

  • Schwarz, B.E., Sem-Jacobsen, C.W., Petersen, M.C.: Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man. Arch. Neurol. Psychiat. (Chic.) 75, 579–587 (1956)

    CAS  Google Scholar 

  • Schwarz, C.J.: The complications of LSD: a review of the literature. J. nerv. ment. Dis. 146, 174–186 (1968)

    PubMed  CAS  Google Scholar 

  • Silverstein, A.B., Klee, G.D.: Effects of lysergic acid diethylamide (LSD-25) on intellectual functions. Arch. Neurol. Psychiat. (Chic.) 80, 477–480 (1958a)

    CAS  Google Scholar 

  • Silverstein, A.B., Klee, G.D.: A psychopharmacological test of the “body image” hypothesis. J. nerv. ment. Dis. 121, 323–329 (1958b)

    Google Scholar 

  • Silverstein, A.B., Klee, G.D.: The effect of lysergic acid diethylamide on digit span. J. clin. exp. Psychopath. 21, 11–14 (1960a)

    CAS  Google Scholar 

  • Silverstein, A.B., Klee, G.D.: The effect of lysergic acid diethylamide on dual pursuit performance. J. clin. exp. Psychopath. 21, 300–303 (1960b)

    Google Scholar 

  • Siva Sankar, D.V., Gold, E., Sankar, B., McRorie, N.: Effect of psychopharmacological agents on DPN-dependent enzymes. Fed. Proc. 20, 394 (1961)

    Google Scholar 

  • Sloane, B., Lovett Doust, J.W.: Psychophysiological investigations in experimental psychoses: results of the exhibition of d-lysergic acid diethylamide to psychiatric patients. J. ment. Sci. 100, 129–144 (1954)

    PubMed  CAS  Google Scholar 

  • Smart, R.G., Storm, T., Baker, E.F.W., Solursh, L.: A controlled study of lysergide in the treatment of alcoholism. I. The effects on drinking behavior. Quart. J. Stud. Alcohol. 27, 469–482 (1966)

    PubMed  CAS  Google Scholar 

  • Smith, C.M.: A new adjunct to the treatment of alcoholism: the hallucinogenic drugs. Quart. J. Stud. Alcohol. 19, 406–417 (1958)

    PubMed  CAS  Google Scholar 

  • Smith, R.P.: The effect of LSD-25 and atropine upon figural after-effects. Pharmacologist 2, 72 (1960)

    Google Scholar 

  • Smorto, G., Corrao, F., Pagano, M.: Sulle modificazioni psicopatologiche indotte dall’acido lisergico (dietilamide). Pisani 69, 39 (1955)

    Google Scholar 

  • Snow, P.J.D., Lennard-Jones, J.E., Curzon, G., Stacey, R.S.: Humoral effects of metastasising carcinoid tumours. Lancet 1955II, 1004–1009

    Google Scholar 

  • Sokoloff, L., Perlin, S., Kornetsky, C., Kety, S.S.: The effects of d-lysergic acid diethylamide on cerebral circulation and over-all metabolism. Ann. N.Y. Acad. Sci. 66, 468–477 (1957)

    PubMed  CAS  Google Scholar 

  • Solms, H.: Lysergsäure-äthylamid (LAE), ein neues, stark sedativ wirkendes Psychoticum aus dem Mutterkorn. Schweiz. med. Wschr. 83, 356–361 (1953)

    PubMed  CAS  Google Scholar 

  • Solms, H.: Relationships between chemical structure and psychoses with the use of psychotoxic substances. “Comparative pharmacopsychiatric analysis”: A new research method. J. clin. exp. Psychopath. 17, 429–433 (1956a)

    PubMed  CAS  Google Scholar 

  • Solms, H.: Chemische Struktur und Psychose bei Lysergsäure-Derivaten. Praxis 45, 746–749 (1956b)

    PubMed  CAS  Google Scholar 

  • Soskin, R.A.: The use of LSD in time-limited psychotherapy. J. nerv. ment. Dis. 157, 410–419 (1973)

    PubMed  CAS  Google Scholar 

  • Spencer, A.M.: Permissive group therapy with lysergic acid diethylamide. Brit. J. Psychiat. 109, 37–45 (1963)

    PubMed  CAS  Google Scholar 

  • Stévenin, L., Benoit, J.C.: L’utilisation des médicaments psychotropes en psychothérapie. Encéphale 51, 420–459 (1962)

    PubMed  Google Scholar 

  • Stoll, W.A.: Lysergséure-diäthylamid, ein Phantastikum aus der Mutterkorngruppe. Schweiz. Arch. Neurol. Psychiat. 60, 279–323 (1947)

    Google Scholar 

  • Stoll, W.A.: Rorschach-Versuche unter Lysergsäure-Diäthylamid-Wirkung. Rorschachiana 1, 249–270 (1952)

    Google Scholar 

  • Stoll, A., Hofmann, A.: Partialsynthese von Alkaloiden vom Typus des Ergobasins. Helv. chim. Acta 26, 944–965 (1943)

    CAS  Google Scholar 

  • Takashina, K.: Physiological studies of visual symptoms due to the effects of hallucinogenic agent LSD 25 on the critical fusion frequency of flicker, the electric flicker threshold, and the intensity threshold for light. Psychiat. Neurol. jap. 62, 1745–1757, 109–110 (1960)

    Google Scholar 

  • Tallaferro, A.: Mescalina y L.S.D. 25. Experiencias, valor terapéutico en psiquiatría. Buenos Aires: Libreria juridica de Valerio Abeledo 1956

    Google Scholar 

  • Tenenbaum, B.: Group therapy with LSD-25. A preliminary report. Dis. nerv. Syst. 22, 459–462 (1961)

    PubMed  CAS  Google Scholar 

  • Thompson, R.H.S., Tickner, A., Webster, G.R.: The action of lysergic acid diethylamide on mammalian cholinesterases. Brit. J. Pharmacol. 10, 61–65 (1955)

    PubMed  CAS  Google Scholar 

  • Thuring, J.P.: The influence of LSD on the handwriting pressure curve. Advanc. psychosom. Med. (Basel) 1, 212–216 (1960)

    CAS  Google Scholar 

  • Tonini, G., Montanari, C.: Effects of experimentally induced psychoses on artistic expression. Confin. neurol. (Basel) 15, 225–239 (1955a)

    CAS  Google Scholar 

  • Tonini, G., Montanari, C.: Effetti psichici della monoetilamide dell’acido lisergico (Lae 32). G. Psichiat. Neuropat. 83, 355–357 (1955b)

    PubMed  CAS  Google Scholar 

  • Trube-Becker, E.: Drogenabusus mit Todesfolge. Med. Klin. 70, 133–140 (1975)

    PubMed  CAS  Google Scholar 

  • Turner, W.J., Almudevar, M., Merlis, S.: Chemotherapeutic trials in psychosis: III. Addendum. 2-Brom-d-lysergic acid diethylamide (BOL). Amer. J. Psychiat. 116, 261–262 (1959)

    PubMed  CAS  Google Scholar 

  • Ungerleider, J.T., Fisher, D.D., Fuller, M.: The dangers of LSD. Analysis of seven months’ experience in a university hospital’s psychiatric service. J. Amer. med. Ass. 197, 389–392 (1966)

    CAS  Google Scholar 

  • Ungerleider, J.T., Fisher, D.D., Fuller, M., Caldwell, A.: The “bad trip” — The etiology of the adverse LSD reaction. Amer. J. Psychiat. 124, 1483–1490 (1968a)

    PubMed  CAS  Google Scholar 

  • Ungerleider, J.T., Fisher, D.D., Goldsmith, S.R., Fuller, M., Forgy, E.: A statistical survey of adverse reactions to LSD in Los Angeles County. Amer. J. Psychiat. 125, 352–357 (1968b)

    Google Scholar 

  • Van Dusen, W., Wilson, W., Miners, W., Hook, H.: Treatment of alcoholism with lysergide. Quart. J. Stud. Alcohol. 28, 295–304 (1967)

    PubMed  Google Scholar 

  • Van Lennep, J.E.: Performance on some projective tests under LSD-25. Advanc. psychosom. Med. 1, 219–222 (1960)

    Google Scholar 

  • Van Rhijn, C.H.: Symbolysis: Psychotherapy by symbolic presentation. In: The Use of LSD in Psychotherapy. Transactions of a Conference on D-Lysergic Acid Diethylamide (LSD-25). April 22–24, 1959. Abramson, H.A. (ed.), pp. 151–197. New York: Josiah Macy, Jr., Foundation 1960

    Google Scholar 

  • Von Felsinger, J.M., Lasagna, L., Beecher, H.K.: The response of normal men to lysergic acid derivatives (di-and mono-ethyl amides). Correlation of personality and drug reactions. J. clin. exp. Psychopathol. 17, 414–428 (1956)

    Google Scholar 

  • Von Mering, O., Morimoto, K., Hyde, R.W., Rinkel, M.: Experimentally induced depersonalization. In: Experimental Psychopathology. Hoch, P.H., Zubin, J. (eds.), pp. 66–77. New York-London: Grune and Stratton 1957

    Google Scholar 

  • Wapner, S., Krus, D.M.: Behavioral effects of lysergic acid diethylamide (LSD-25). Space localization in normal adults as measured by the apparent horizon. Arch. gen. Psychiat. 1, 417–419 (1959)

    CAS  Google Scholar 

  • Wapner, S., Krus, D.M.: Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop color-word test. J. Neuropsychiat. 2, 76–81 (1960)

    PubMed  CAS  Google Scholar 

  • Weintraub, W., Silverstein, A.B., Klee, G.D.: The effect of LSD on the associative processes. J. nerv. ment. Dis. 128, 409–414 (1959)

    PubMed  CAS  Google Scholar 

  • Weintraub, W., Silverstein, A.B., Klee, G.D.: The “correction” of deviant responses on a word association test. A measure of the defensive functions of the ego. Arch. gen. Psychiat. 3, 17–20 (1960)

    PubMed  CAS  Google Scholar 

  • Whitaker, L.H.: Lysergic acid diethylamide in psychotherapy. Med. J. Aust. 51 (I), 5–8, 36–41 (1964)

    Google Scholar 

  • Wijsenbeek, H., Landau, R.: A review on the use of lysergic acid diethylamide (LSD-25) in psychiatry. Harefuah 58, 281–286 (1960)

    PubMed  CAS  Google Scholar 

  • Wikler, A., Haertzen, C.A., Chessick, R.D., Hill, H.E., Pescor, F.T.: Reaction time (“mental set”) in control and chronic schizophrenic subjects and in postaddicts under placebo, LSD-25, morphine, pentobarbital and amphetamine. Psychopharmacologia (Berl.) 7, 423–443 (1965a)

    CAS  Google Scholar 

  • Wikler, A., Rosenberg, D.E., Hawthorne, J.D., Cassidy, T.M.: Age and effect of LSD-25 on pupil size and kneejerk threshold. Studies in chronic schizophrenic and nonpsychotic subjects. Psychopharmacologia (Berl.) 7, 44–56 (1965b)

    CAS  Google Scholar 

  • Wolbach, A.B., Isbell, H., Miner, E.J.: Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions. Psychopharmacologia (Berl.) 3, 1–14 (1962)

    CAS  Google Scholar 

  • Woolley, D.W.: Serotonin in mental disorders. Res. Publ. Ass. nerv. ment. Dis. 36, 381–400 (1958)

    CAS  Google Scholar 

  • Woolley, D.W., Shaw, E.: A biochemical and pharmacological suggestion about certain mental disorders. Proc. nat. Acad. Sci. (Wash.) 40, 228–231 (1954)

    CAS  Google Scholar 

  • Young, B.: A phenomenological comparison of LSD and schizophrenic states. Brit. J. Psychiat. 124, 64–74 (1974)

    PubMed  CAS  Google Scholar 

  • Zehnder, K., Cerletti, A.: Hemmung der Menschenserum-Pseudocholinesterase durch Lysergsäurediäthylamid und 2-Brom-Lysergsäurediäthylamid. Helv. physiol. pharmacol. Acta 14, 264–268 (1956)

    PubMed  CAS  Google Scholar 

  • Ziolko, H.U.: Psychotrope Drogenwirkungund psychische Ausgangslage (Neurose). In: Neuro-Psychopharmacology. Proc. 1st Int. Congr. Neuro-Psychopharmacology, Rome, Sept. 1958. Bradley, P.B., Deniker, P., Radouco-Thomas, C. (eds.), pp. 711–713. Amsterdam-London-New York-Princeton: Elsevier 1959

    Google Scholar 

  • Zsigmond, E.K., Foldes, F.F., Foldes, V., Erdos, E.G.: The in vitro inhibitory effect of d-lysergic acid (LSD) and its congeners on human cholinesterases. Fed. Proc. 18, 463 (1959)

    Google Scholar 

  • Zsigmond, E.K., Foldes, F.F., Foldes, V.: The lack of correlation between the psychopharmacologic and anticholinesterase effect of LSD and its congeners. Fed. Proc. 19, 266 (1960)

    Google Scholar 

Download references

Authors
  1. A. Fanchamps
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Forschung und Entwicklung, Pharmazeutisches Departement, Sandoz AG, 4002, Basel, Schweiz

    B. Berde

  2. University College London, London WC1, Great Britain

    H. O. Schild (Emeritus Professor of Pharmacology in the University of London) (Emeritus Professor of Pharmacology in the University of London)

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Fanchamps, A. (1978). Some Compounds With Hallucinogenic Activity. In: Berde, B., Schild, H.O. (eds) Ergot Alkaloids and Related Compounds. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 49. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66775-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66775-6_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66777-0

  • Online ISBN: 978-3-642-66775-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation